Invesco's QQQ celebrates silver anniversary on a roll

Invesco's QQQ celebrates silver anniversary on a roll
The exchange-traded fund is up 7.3 percent year-to-date and 50.7 percent over the past year, a heck of an anniversary present for investors.
MAR 12, 2024

The Invesco QQQ ETF is celebrating silver anniversary this year as it marks 25 years of existence. The returns thus far in 2024 have been pure gold. The question facing investors now is whether the fund can make that "magnificent" momentum last.

The QQQ tracks the Nasdaq-100, an index of 100 largest nonfinancial companies listed on the Nasdaq. The QQQ is up 7.3 percent year to date and 50.7 percent over the past 12 months. That’s a heck of an anniversary present for investors, outpacing the S&P 500 index, which is up 7.1 percent this year and 30.3 percent over the past year.

The QQQ is the fifth largest ETF in the world, with net assets of $254 billion, or about half the size of the largest ETF, the SPDR S&P 500 ETF Trust (SPY).

Of course, the QQQ is a far more concentrated index than the S&P 500, both in terms of the number of stocks and the number of sectors represented. It’s also on a “magnificent” run because a full seven of its top seven holdings are members of the so-called “Magnificent 7” – Alphabet, Amazon, Apple, Meta, Microsoft, Nvidia, and Tesla – a group of stocks that has surged over the past year due to its members’ AI associations.

Microsoft, for example, makes up 8.8 percent of the QQQ and is up 12 percent in 2024 and 63.5 percent over the past 12 months. NVDA is 5.6 percent of the QQQ and is up a whopping 91 percent in 2024 and 300 percent in the past 12 months. And so on.

The worry among investors and their advisors is that the Magnificent 7 could lead the QQQ down just as fast as it led it up. Sure the QQQ was up 55 percent in 2023, but it also fell more than 32.5 percent when markets fell apart in 2022.

Paul Schroeder, QQQ equity product strategist at Invesco, understands investors' concerns over concentration, saying it's not unusual to see the top 10 holdings comprise a major part of the overall fund.

“Right now, the top 10 stocks make up just about 48%,” Schroeder said. “So it's not a new trend, and [it's] something that we've seen play out throughout the years. And really, we see a lot of those companies have expanded and become a major part of just the broader market in general.” 

Mark Marex, senior director of index research and development at Nasdaq, notes that while concentration is a factor in the makeup of the underlying index, they do “adjust the weights on a quarterly and on an annual basis to make sure that there isn't too much excess concentration.”

QQQ: AN INNOVATION SENSATION

The secret ingredient behind the success of the companies held in the QQQ is innovation, Schroeder says. And that innovation can be measured by the company's relative spending on research and development.  

“We see your average QQQ company outspending your average S&P 500 company on research and development by about 2 to 1,” he said. “If you take out the Q's companies from the S&P 500, that metric goes up to 15 to 1. So really, we've seen these US companies grow and become the cream of the crop of the S&P 500 when it comes to innovation.” 

Schroeder also tips his hat to the Nasdaq for “attracting new technologically focused companies to list on their exchange.

“We've also launched other products that go into what we call the ‘broader innovation suite,’ so you're now able to gain exposure not only to large-cap growth but also mid-cap growth through QQQJ, and also a small-cap growth through QQQS,” he said.

Marex also sees the Nasdaq-100 as being in the “innovation space,” and, as such, more diversified than people might think despite its heavy weightings in technology, consumer discretionary and health care.

“It's not even a US-only index, technically speaking, because you just have to be Nasdaq-listed,” he said. “We have a handful of internationally based companies that are included in the index year in and year out. So again, I think it's a very unique kind of diversified way to play the innovation space in large-cap equities. And that's what really sets it apart.”

Here's why tech, health care stocks will lead market higher again in 2024

Latest News

RIA M&A stays brisk in first quarter with record pace of dealmaking
RIA M&A stays brisk in first quarter with record pace of dealmaking

Driven by robust transaction activity amid market turbulence and increased focus on billion-dollar plus targets, Echelon Partners expects another all-time high in 2025.

New York Dems push for return of tax on stock sales
New York Dems push for return of tax on stock sales

The looming threat of federal funding cuts to state and local governments has lawmakers weighing a levy that was phased out in 1981.

Human Interest and Income Lab streamline workflows for retirement-focused advisors
Human Interest and Income Lab streamline workflows for retirement-focused advisors

The fintech firms' new tools and integrations address pain points in overseeing investment lineups, account monitoring, and more.

Buy or sell Canada? Wealth managers watch carefully as Canadians head to the polls
Buy or sell Canada? Wealth managers watch carefully as Canadians head to the polls

Canadian stocks are on a roll in 2025 as the country prepares to name a new Prime Minister.

Carson, Lido strengthen RIA networks with bicoastal deals
Carson, Lido strengthen RIA networks with bicoastal deals

Carson is expanding one of its relationships in Florida while Lido Advisors adds an $870 million practice in Silicon Valley.

SPONSORED Compliance in real time: Technology's expanding role in RIA oversight

RIAs face rising regulatory pressure in 2025. Forward-looking firms are responding with embedded technology, not more paperwork.

SPONSORED Advisory firms confront crossroads amid historic wealth transfer

As inheritances are set to reshape client portfolios and next-gen heirs demand digital-first experiences, firms are retooling their wealth tech stacks and succession models in real time.